Jia Wei

20PUBLICATIONS
38CO-AUTHORS
Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 05, 2026
Novel highly selective ROCK2 inhibitor (TDI01) for the treatment of chronic graft-versus-host disease: a multicenter, open-label phase Ib/II study.

|Aug 04, 2026
Endoplasmic reticulum stress promotes leukemic plasmacytoid dendritic cell differentiation skewing and immune suppression in acute myeloid leukemia.

|Jun 30, 2026
Advances and prospects in cell therapy for cancer: explorations from T cells to stem cells.

|Jun 24, 2026
Febrile neutropenia adversely affects chemomobilization outcomes in patients with multiple myeloma and increases risk for post-transplant infection in those with lymphoma: real-world multicenter data.

|Feb 12, 2026
Long-term follow-up demonstrates the curative potential of dual CD19/CD22 CAR-T-cell therapy alone or combined with autologous stem cell transplantation in TP53-altered relapsed/refractory B-cell non-Hodgkin lymphoma.

Zekai Mao, Juan Peng, Yang Cao

|Feb 05, 2026
Comparative Analysis of T-Cell and Bone Marrow Chimerism for Relapse Prediction in Acute Leukaemia Post-Transplantation.

Chunfeng Li, Tongyuan Liu, Ying Wan

Pageof 4

Frequent Collaborators

4 joint publications

Yicheng Zhang

2 joint publications

Chunrui Li

2 joint publications

Jianfeng Zhou

2 joint publications

Liang Huang